You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR FENOGLIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for FENOGLIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02158273 ↗ Medication Development in Alcoholism: Investigating PPAR Agonists Completed National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phase 2 2014-05-01 The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
NCT02158273 ↗ Medication Development in Alcoholism: Investigating PPAR Agonists Completed The Scripps Research Institute Phase 2 2014-05-01 The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
NCT06191133 ↗ Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma Not yet recruiting Lindsay Ferguson, MD Phase 1 2024-08-01 Normally, p53 helps prevent tumors from forming in the body. Early studies have shown that Fenofibrate, a cholesterol-lowering drug, can restore normal function to p53 and can change the metabolism of HPV-positive tumors in a way that stops the growth of tumors. The purpose of this study is to understand how Fenofibrate can be used to treat HPV-positive cervical cancers and cervical dysplasia. Researchers will examine collected tissue samples and investigate various genes and proteins to see whether Fenofibrate has an effect on HPV-positive cervical cancers and cervical dysplasia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for FENOGLIDE

Condition Name

Condition Name for FENOGLIDE
Intervention Trials
Cervical Intraepithelial Neoplasia 1
Invasive Cervical Cancer 1
Alcoholism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for FENOGLIDE
Intervention Trials
Uterine Cervical Dysplasia 1
Neoplasms 1
Carcinoma in Situ 1
Alcoholism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for FENOGLIDE

Trials by Country

Trials by Country for FENOGLIDE
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for FENOGLIDE
Location Trials
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for FENOGLIDE

Clinical Trial Phase

Clinical Trial Phase for FENOGLIDE
Clinical Trial Phase Trials
Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for FENOGLIDE
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FENOGLIDE

Sponsor Name

Sponsor Name for FENOGLIDE
Sponsor Trials
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 1
The Scripps Research Institute 1
Lindsay Ferguson, MD 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for FENOGLIDE
Sponsor Trials
Other 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.